Advertisement
News
Advertisement

Horizon Pharma gets UK nod for arthritis drug

Fri, 12/21/2012 - 10:19am
The Associated Press

U.K. regulators will grant marketing approval to Horizon Pharma's arthritis combination pill, pending review of a few final documents, the company said Friday.

Duexis is used to treat osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, an inflammatory disease of the spinal bones. The pill combines a prescription-strength dose of ibuprofen with a dose of famotidine, which is intended to prevent stomach ulcers associated with ibuprofen.

Duexis was previously approved in the U.S.

Shares of Horizon Pharma Inc. fell 3 cents, or 1.2 percent, to $2.37.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading